Results for tag: "Axial Spondyloarthritis"

Axial Spondyloarthritis (axSpA) is a chronic inflammatory disorder of the spine and sacroiliac joints, which is classified as a type of arthritis. It is a form of spondyloarthritis, a group of diseases that affect the spine and other joints. Symptoms of axSpA include pain and stiffness in the lower back, hips, and other joints, as well as fatigue and inflammation. Treatment options for axSpA include non-steroidal anti-inflammatory drugs (NSAIDs), disease-modifying anti-rheumatic drugs (DMARDs), and biologic agents. Allergy and Immunology specialists are often involved in the diagnosis and management of axSpA, as the condition is believed to be caused by an autoimmune response. Companies in the axSpA market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Novartis, Pfizer, and UCB. Show Less Read more